IDV vehicle

75N92023D00012

NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NHLBI
NAICS541380 — Testing Laboratories and Services
PSCB599 — Other Special Studies and Analysis
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$500.0M
Start dateSep 13, 2023
Current end dateNot available
Potential end dateNot available
Latest award activityAug 4, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 4, 2026P00001$0EO14398, RFO, INV, NON-COMMERCIAL BOT NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE)
Sep 13, 20230$0NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE)

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Peel, MelanieContactmelanie.peel@nih.gov
301-435-0330
SourceJun 23, 2023
Peel, MelanieContactmelanie.peel@nih.gov
301-435-0330
SourceJun 13, 2023
Peel, MelanieContactmelanie.peel@nih.gov
301-435-0330
SourceMay 25, 2023
Peel, MelanieContactmelanie.peel@nih.gov
301-435-0330
SourceMay 20, 2022
Peel, MelanieContactmelanie.peel@nih.gov
301-435-0330
SourceMay 20, 2022

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.